Trial Profile
Early effects of intravitreal aflibercept injection on optic nerve head morphology in patients with neovascular age related macular degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jun 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 17 Jun 2017 New trial record